According to the report analysis, ‘Asia-Pacific Stable
Isotope Labeled Compound Market Industry Trends Forecast to 2026’ states that there are numerous key
players which are presently functioning in this sector more actively for
leading the fastest market growth and dominating the highest value of market
share around the Asia Pacific region while determining the changing trends in
the market and utilization of such compounds which further benefitted for
increasing the demand and generating the high value of revenue includes IsoSciences, TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Pepscan,
Mesbah Energy Co., BOC Sciences, Isoflex,
Nordion Inc., JSC Isotope, Merck KGaA, URENCO, 3M, Cambridge
Isotope Laboratories, Inc.,
Alsachim, Medical Isotopes, Inc., AMERICAN RADIOLABELED CHEMICALS, INC., Beta Analytics, The State Atomic Energy Corporation ROSATOM, Trace Sciences International, Huayi Isotopes Co., Chemtos and several others.
The stables isotope labeled compound has engendered
significant interest among the researchers involved in the metabolism mediated
toxicity studies. The role of such has increased in the consequence in the
valuation of in vivo metabolism in a wide variety of the metabolic research. The
utilization of the technologies significantly includes a mass spectrometry (MS)
or nuclear magnetic resonance (NMR) has further prolonged the research.
Moreover, the stable isotopically labeled compounds are
anti-radioactive chemical constituents where the component is one or more than
one inside the composite has been replaced for its stable isotope. However, the
technologies have allowed the researcher market the efficient usage of the
stable isotope labeled compound for the estimating drugs’ disposition and their
toxicity profile before they are utilized on the patient populace.
Asia-Pacific stable isotope labeled compound market is
predicted to reach the highest CAGR of 4.1% in the review period of 2019 to
2026. Additionally, the Asia Pacific stable isotope labeled compound market is
sectored into different sectors which majorly involves type, end user and
applications. Whereas, based on the applications the market further split into
clinical diagnostic, industrial and research. For instance, the research sector
has significant increased the largest market share as owing to its utilization
in the amalgamation of stable isotopes methods with the nuclear magnetic
resonance spectroscopy and mass spectroscopy which has encouraged in superior
usage in the preoccupation, metabolism and evacuation studies during research.
The corporate stable isotope labeled compounds are 2H
(Deuterium or D), 13C, 15N and 18O. Away from each other the metabolomics
studies, stable isotope-labeled compounds are being progressively utilized in the
conservational analysis, proteomics, and medical diagnostic research. Moreover,
the increasing body of research on the pharmaceutical and biotechnology
industries is a majoraspect of underpinning the speedy advancement of the
stable isotope-labeled compounds market. The significant increase in the aim on
quickening the authentication of the new treatment modalities in order to
decrease the morbidity and mortality in pediatric populace is a foremost trend
booming up the market.
Nonetheless, the increasing requirement for the
research in biology, medicine and pharmaceuticals is a foremost market growth
opportunity. Therefore, in the coming years, it is predicted that the market of
stable isotope labelled compound will increase across the Asia Pacific region
more positively over the coming years.
For more information on the research
report, refer to below link:
Related reports
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
